Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.62 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | NCF1 | P14598 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10178474 | 0.98 | HRH3 (0.59) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| SCHEMBL12017826 | 0.85 | LMNA (0.57) | HRH3ALDH1A1KDM4ENCF1 | |
| SCHEMBL11139655 | 0.84 | HRH3 (0.69) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| SCHEMBL10077424 | 0.83 | HRH3 (0.59) | HRH3ALDH1A1MEN1KMT2A | |
| SCHEMBL12017823 | 0.83 | SIGMAR1 (0.54) | HRH3ALDH1A1MEN1KMT2A | |
| SCHEMBL6227511 | 0.83 | HRH3 (0.57) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| SCHEMBL14847024 | 0.82 | HRH3 (0.67) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL7404903 | 0.82 | HRH3 (0.67) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| SCHEMBL1935806 | 0.82 | HRH3 (0.67) | HRH3HRH4ALDH1A1KDM4EMEN1 | |
| SCHEMBL14274074 | 0.82 | CXCR4 (0.57) | HRH3ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3971171-B1 | OXAZOLINE COMPOUND, SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF | UNIV NANKAI (CN) | 2023-11-01 | — | — | EP | disclosed |
| US-10849337-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | CADENA BIO, INC. (US) | 2020-12-01 | — | — | US | disclosed |
| US-8124310-B2 | Positive resist composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20090087784-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10849337-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | HRH3 4301/4885HRH4 3849/4885ALDH1A1 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.